Spot Diagnosis surpasses 30,000 downloads

A note from Skin Health Institute Spot Diagnosis podcast creator A/Prof Alvin Chong 

‘We launched Spot Diagnosis podcast just as the COVID pandemic was declared, in March 2020. Our aim was to provide monthly, evidence-based teaching for medical students and GPs using a free podcast platform and Spot Diagnosis Podcast has now been going for nearly three years. We have published 33 episodes on a range of skin diseases – from acne to psoriasis to melanoma. Amazingly, not only have we found a willing audience locally, but our episodes have also been downloaded over 30,000 times in 109 countries, with each episode averaging more than 700 downloads. We are on the resource lists of many medical schools in Australia and we have been accredited for RACGP and ACCRM CPD education.   

 It really takes a village to produce something special like the Spot Diagnosis Podcast. We are incredibly grateful for the support given by the Skin Health Institute, particularly the tireless work done by Ms Jo Coughlin. Jo has been with us from the beginning and has edited every single episode that we have produced. My co-hosts – Dr Tom Kovi, Dr Blake Mumford, Dr Anneliese Willems, Dr Sarah Adamson and A/Prof Aaron Robinson have each worked hard and brought their own personalities and skills to the podcasts. I would also like to thank my specialist colleagues, all of whom had given up their time and expertise to help us record these episodes, and Ms Jasmine Crouch for her help with social media. And finally, the excellent podcast recording team at Balloon Tree Productions.  

 I am always thrilled when medical students and GPs tell me that they have listened to the podcast. I believe that in educating our health professionals about skin disease, we are contributing to the skin health of our community.’  

   – Spot Diagnosis podcast creator, A/Prof Alvin Chong 

 We would like to thank our Institute Partner Melbourne Pathology for their support of the Spot Diagnosis Podcast.  

Psoriasis, a chronic inflammatory skin condition, affects millions of individuals worldwide, including a significant number of Australians. This August, during Psoriasis Awareness Month, we aim to shed light on this prevalent condition, raise awareness, and emphasise the importance of empathy and support for those living with psoriasis.

In Australia, psoriasis is estimated to impact approximately 2-3% of the population, making it a relatively common dermatological concern. Despite its prevalence, psoriasis remains widely misunderstood, leading to misconceptions and stigmatisation among patients.

At the Skin Health Institute, we have committed our support to Psoriasis Awareness Month with a mission to create empathy and awareness for people with psoriasis and promote a better understanding of this condition. We recognise that beyond medical treatment, patients need compassionate support and understanding from their communities. Through various initiatives, we strive to foster an environment of compassion and knowledge, allowing patients to feel heard and supported as they learn to manage their condition.

Our dedication to enhancing dermatological care extends to providing the latest treatment options. Our Advanced Targeted Therapies Clinic offers cutting-edge therapies that specifically address psoriasis, tailored to each patient’s unique needs. Our expert dermatologists work closely with patients to develop personalised treatment plans, empowering them to manage their condition effectively and improve their quality of life.

Education is key to unlocking progress in dermatology, so through our suite of educational resources, we seek to help health professionals to stay at the forefront of their clinical practice. Our Masterclasses, GP Workshops, Advanced Therapeutics Education Portal, and Spot Diagnosis podcast episodes provide valuable insights and updates on psoriasis management and treatment options.

As part of our commitment to advancing psoriasis research, we are actively conducting clinical trials focused on nail and body psoriasis. These trials play a crucial role in uncovering innovative treatments and improving outcomes for people with psoriasis. By participating in our clinical trials, individuals not only contribute to medical advancements but also have the opportunity to access potential breakthrough therapies.

During Psoriasis Awareness Month and beyond, we stay dedicated in the pursuit of improving patient outcomes, expanding healthcare professional knowledge and advancing treatment options.         

Scroll to Top